Life science. In the making.
Inside the science, the culture, and the claims reshaping the peptide frontier.
The cover story
Dispatch / analysis
Six months ago, the most consequential drug launch of the decade happened on a Thursday in April and most of the internet missed it: Foundayo, the first once-daily weight-loss pill with no food or water restrictions, went on sale.
Read the story ↗Selected reading
Field guide↗
Before you spend a dollar, five things the communities wish someone had told them on day one.
Field guide↗
This category is a 14-product market built on almost no human clinical evidence — and it runs anyway, because tens of thousands of people with stubborn tendon, ligament, and gut complaints say they've run out of other options. The research files behind this review cover every item, priced and tiered from real community observation (September 2026). Here is what that evidence actually supports, and what it doesn't.
Field guide↗
Growth hormone secretagogues are the peptide scene's workaround for an awkward fact: actual human growth hormone is expensive, prescription-only, and counterfeited relentlessly. Instead of injecting GH itself, these compounds nudge your own pituitary to pulse more of it — either by mimicking GHRH, the "go" signal (CJC-1295, sermorelin, tesamorelin), or by hitting the ghrelin receptor, the "amplify" signal (ipamorelin, the GHRPs, hexarelin).
The compound index
Healing & recovery↗
BPC-157 is the undisputed king of healing-peptide discourse — no other compound generates this volume of recovery anecdotes across Threads, Instagram, and Facebook groups. But the praise is almost entirely experiential: community consensus is that it pairs well with TB-500, sourcing/quality is the real risk, and the clinical evidence base is limited to animal work and one tiny published human pilot.
Metabolic & weight loss↗
Semaglutide is the reference standard of the GLP-1 era: the one with the deep trial program (STEP), the hard outcomes (SELECT, FLOW), and the largest real-world user base — and the community treats it as such, with practical titration wisdom rather than hype. The persistent community complaints are cost/access and GI side effects during dose escalation, plus real anxiety about lifelong use given weight regain after stopping.
Healing & recovery↗
GHK-Cu is the cosmetic darling of the healing category — hair and skin anecdotes are abundant and it anchors the GLOW triple stack — but injectable use is the least evidence-backed application of the five compounds here. Community sentiment splits between believers citing visible skin/hair change and skeptics noting the benefits never quite materialize; everyone agrees the topical form is the one with real data behind it.
Immune & antimicrobial↗
Epithalon is the longevity half of this track's biggest viral story — huge reach, thin ownership. The telomerase narrative is its engine and its risk: the same mechanism that excites buyers alarms cautious commenters.
Read critically
Community signals, clinical research, and regulatory status answer different questions. Our dossiers show their sources and limitations so you can inspect the distinctions.
How we approach the evidence ↗From the community
A question worth investigating. A source we missed. A first-hand perspective. Help shape what we cover next.
